Free Trial

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Stock Position in Envista Holdings Co. (NYSE:NVST)

Envista logo with Medical background

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Envista Holdings Co. (NYSE:NVST - Free Report) by 15.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 492,736 shares of the company's stock after acquiring an additional 67,234 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.29% of Envista worth $9,505,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Ariel Investments LLC grew its holdings in Envista by 6.2% during the fourth quarter. Ariel Investments LLC now owns 12,059,624 shares of the company's stock valued at $232,630,000 after purchasing an additional 699,625 shares during the period. Franklin Resources Inc. grew its holdings in Envista by 72.6% during the fourth quarter. Franklin Resources Inc. now owns 6,854,506 shares of the company's stock valued at $132,223,000 after purchasing an additional 2,882,844 shares during the period. Dimensional Fund Advisors LP grew its holdings in Envista by 19.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 6,762,091 shares of the company's stock valued at $130,440,000 after purchasing an additional 1,089,923 shares during the period. Gates Capital Management Inc. grew its holdings in Envista by 15.1% during the fourth quarter. Gates Capital Management Inc. now owns 4,694,148 shares of the company's stock valued at $90,550,000 after purchasing an additional 615,577 shares during the period. Finally, Massachusetts Financial Services Co. MA lifted its position in shares of Envista by 9.5% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,271,175 shares of the company's stock valued at $63,101,000 after acquiring an additional 283,415 shares in the last quarter.

Analyst Ratings Changes

NVST has been the topic of several research analyst reports. Needham & Company LLC restated a "hold" rating on shares of Envista in a research report on Thursday, March 6th. Morgan Stanley set a $16.00 price objective on Envista in a research report on Tuesday, April 15th. UBS Group lowered their price objective on Envista from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Monday, May 5th. Baird R W upgraded Envista from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 27th. Finally, Robert W. Baird upgraded Envista from a "neutral" rating to an "outperform" rating and boosted their price objective for the company from $21.00 to $23.00 in a research report on Tuesday, May 27th. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $20.23.

Get Our Latest Stock Analysis on NVST

Envista Trading Up 0.2%

Shares of NVST traded up $0.04 during mid-day trading on Wednesday, reaching $18.77. 1,611,408 shares of the company's stock traded hands, compared to its average volume of 2,567,587. The stock has a market cap of $3.18 billion, a P/E ratio of -2.89, a P/E/G ratio of 1.27 and a beta of 0.99. The stock's 50-day moving average is $16.72 and its two-hundred day moving average is $18.71. Envista Holdings Co. has a 12 month low of $14.22 and a 12 month high of $23.00. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76.

Envista (NYSE:NVST - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.04. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. The company had revenue of $616.90 million for the quarter, compared to analysts' expectations of $608.17 million. During the same quarter in the prior year, the firm earned $0.26 earnings per share. Envista's revenue was down 1.1% compared to the same quarter last year. Research analysts forecast that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Envista Profile

(Free Report)

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

Read More

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June
3 Defense Stocks Set to Crush the S&P This Summer

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines